Oral rinse MMP-8 point-of-care immuno test identifies patients with strong periodontal inflammatory burden
Artículo
Open/ Download
Publication date
2011Metadata
Show full item record
Cómo citar
Leppilahti, Jussi
Cómo citar
Oral rinse MMP-8 point-of-care immuno test identifies patients with strong periodontal inflammatory burden
Author
Abstract
OBJECTIVE: To determine whether oral rinse matrix
metalloproteinase (MMP)-8 levels, measured by three
different methods, tissue inhibitor of matrix metalloprotease-
1 (TIMP-1) levels and elastase activity differentiate
subjects with different periodontal condition; and second,
to find out if MMP-8 levels were comparable among the
methods used.
METHODS: MMP-8 levels were analysed with an immunofluorometric
method (IFMA), dentoELISA and commercial
ELISA. Also TIMP-1 levels and elastase activity
were measured. For statistical analysis 214 study subjects
were categorized into four groups, specified by the
presence and number of moderate (4–5 mm) and deep
(‡6 mm) periodontal pockets, and bleeding on probing
percentage.
RESULTS: MMP-8 levels especially measured by dentoELISA
and adjusted to the number of teeth per subject
differentiated the study group with strong periodontal
inflammatory burden from groups with lower levels. This
was also verified with receiver operating characteristic
(ROC) analysis. Elastase activity associated with higher
IFMA and dentoELISA MMP-8 levels. IFMA MMP-8 ⁄ TIMP
and dentoELISA MMP-8 ⁄ TIMP-1 tended to be higher
with the increasing level of periodontal inflammatory
burden. TIMP-1 levels decreased with increasing age.
CONCLUSIONS: Oral rinse MMP-8 together with
TIMP-1 analysis may have potential in complementary
periodontal diagnostics. dentoELISA can be applied in
quantitative oral rinse chair side biomarker diagnostics.
General note
Artículo de publicación ISI
Patrocinador
This study was supported by grants from the Academy of
Finland, the Research Foundation of Helsinki University
Central Hospital, the Finnish Dental Society Apollonia and
the Fondecyt Foundation of Chile. Timo Sorsa is an inventor
of US-patents 5652227, 5736341, 5866432 and 6143476.
Identifier
URI: https://repositorio.uchile.cl/handle/2250/123422
DOI: doi:10.1111/j.1601-0825.2010.01716.x
Quote Item
Oral Diseases (2011) 17, 115–122
Collections